RPA 32 kDa subunit activators represent a class of molecules that have been recognized to stimulate the activity or expression of the RPA 32 kDa subunit, also known as RPA2. The RPA complex, of which RPA2 is a crucial component, is involved in several key processes related to DNA metabolism, including DNA replication, repair, recombination, and telomere maintenance. The RPA2 subunit has a distinct role in binding single-stranded DNA and is vital for stabilizing these structures during the aforementioned processes. Consequently, molecules capable of activating this protein influence these essential cellular functions.
The specific mechanisms through which RPA 32 kDa subunit activators function can differ greatly depending on the particular molecule. Some may directly influence RPA2, augmenting its capacity to bind target proteins or modulating its interaction with these proteins. Other activators could function indirectly by affecting the expression of the RPA2 protein. For example, they might impact the transcription or translation of the RPA2 gene, thereby increasing the abundance of RPA2 in the cell. Some activators might also influence upstream or downstream signaling pathways that consequently affect RPA2 activity or expression. Regardless of their specific mechanisms of action, all RPA 32 kDa subunit activators share the same overall effect of enhancing the activity or expression of RPA2. They hold considerable interest for researchers investigating the intricate role of the RPA complex in cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin might induce RPA2 expression due to its role in modulating cellular stress response pathways. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium Butyrate could potentially affect RPA2 expression through its action on histone deacetylase inhibition. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine might influence RPA2 expression due to its action on DNA methylation. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol might modulate RPA2 expression due to its interactions with cellular antioxidant pathways. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
(-)-Epigallocatechin Gallatemight influence RPA2 expression through its effects on cellular oxidative stress. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid could potentially upregulate RPA2 due to its action on retinoid signaling. | ||||||
Parthenolide | 20554-84-1 | sc-3523 sc-3523A | 50 mg 250 mg | $81.00 $306.00 | 32 | |
Parthenolide could potentially induce RPA2 expression as part of its effects on NF-κB signaling. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D could potentially induce RPA2 expression due to its effects on transcription inhibition. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A might enhance RPA2 expression via its histone deacetylase inhibitory properties. | ||||||
Salicylic acid | 69-72-7 | sc-203374 sc-203374A sc-203374B | 100 g 500 g 1 kg | $47.00 $94.00 $119.00 | 3 | |
Salicylic Acid might enhance RPA2 expression by affecting cellular stress response pathways. | ||||||